ALK and non-small cell lung carcinoma: Finally, we carried out a Receiver Operating Characteristic (ROC) Curve analysis to further evaluate the predictive capacity of DBP in NSCLC, reporting an area under the curve (AUC) of 0.94 (Fig. 1D), and demonstrating that DBP was an excellent binary predictor in this representative subset of cell lines and ALK inhibitors.